医療用吸入器市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00018804
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

市場紹介 医療用吸入器は、吸入を介してさまざまな薬剤を送達するために使用される医療機器です。吸入器で使用される薬剤には、喘息や慢性閉塞性肺疾患などの呼吸器疾患の治療と予防のための抗コリン薬、グルココルチコイド、インスリン、ベータ作動薬が含まれます。スマート吸入器は、吸入器にクリップとして取り付けられたセンサーを備えた医療用吸入器の一種で、1回の摂取当たりの適切な投与量と薬剤の吸入に使用される技術を監視します。センサーによって取得されたデータは、吸入器の使用状況を追跡するために患者および医療専門家と共有されます。他の異なるタイプの吸入器には、ドライパウダー吸入器、定量吸入器などが含まれます。 市場ダイナミクス 医療用吸入器市場は、予測期間中に大きな進化を示しました。医療用吸入器市場の隆盛は、喘息や慢性閉塞性肺疾患に苦しむ人々の有病率の増加と、より優れたスマート吸入器デバイスおよびシステムの開発における技術進歩によって推進されています。さらに、標準的な医療インフラの改善に向けた政府の取り組みと医療支出への注目の高まりにより、これらの国は質の高い医療の提供に注力することができています。大多数の人々が罹患している喘息や慢性閉塞性肺疾患(COPD)などの疾患を管理するために、綿密な努力が払われてきました。 WHO によると、世界で 3 億人以上が喘息に罹患しており、2016 年までに 2 億人以上が COPD に罹患しているとのことです。しかし、喘息と COPD 用の医療用吸入器の開発に伴うコストの上昇により、喘息の発症は抑制されると予想されています。医療用吸入器市場の成長。 市場範囲 「2031年までの医療用吸入器市場分析」は、世界市場動向分析に焦点を当てた、ヘルスケア業界の医療機器の専門的かつ詳細な調査です。このレポートは、製品、アプリケーション、エンドユーザーごとに詳細な市場分割を行い、医療用吸入器市場の概要を説明します。医療用吸入器市場は、予測期間中に大幅に上昇すると推定されています。これは、医療用吸入器市場における主要企業の市場状況に関する重要な統計に焦点を当てており、市場における重要な機会と傾向を提供します。 市場セグメンテーション 市場は、製品、アプリケーション、エンドユーザーに基づいて分類されます。製品に基づいて、市場は乾燥粉末吸入器、定量吸入器などに分類されます。アプリケーションに基づいて、市場は喘息、慢性閉塞性肺疾患、その他に分類されます。エンドユーザーに基づいて、市場は病院、診療所、呼吸器ケアセンターなどに分類されます。 このレポートには、定量的情報と定性的情報の両方で構成される業界の詳細な概要が記載されています。さまざまなセグメントに基づいて医療用吸入器市場の概要と予測を提供します。レポートには、5 つの主要地域に関する 2021 年から 2031 年までの市場規模と予測推定も含まれています。北米、アジア太平洋 (APAC)、ヨーロッパ、中東、アフリカ (MEA)、および南中米 (SCAM)。各地域ごとの医療用吸入器市場は、それぞれの国とセグメントにサブセグメント化されます。これは、世界 18 か国の分析と予測、およびこの地域で広まっている最近の傾向と機会で構成されています。このレポートは、需要側と供給側の両方から医療用吸入器市場に影響を与える要因を分析しています。さらに、予測期間中の市場に関する市場ダイナミクス、つまり推進力、制約、機会、将来の傾向を評価します。また、医療用吸入器市場に影響を与える政治的、社会的、経済的、技術的要因を評価した後、北米、アジア太平洋、ヨーロッパ、中東、アフリカ、中南米の5つの地域すべてに対する正確なPEST分析で構成されています。これらの地域では。 市場関係者 このレポートには、無機および有機成長戦略としての医療用吸入器市場における重要な展開が含まれています。いくつかの企業は、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に重点を置いています。観察された無機的な成長戦略は、コラボレーション、買収、パートナーシップでした。このようなさまざまな活動により、市場参加者のビジネスと顧客ベースを精緻化するための道が開かれてきました。医療用吸入器市場のプレーヤーは、世界市場における医療用吸入器の需要の高まりにより、今後数年間で収益性の高い成長の機会があると推定されています。以下は、医療用吸入器市場に従事する数社のリストです。このレポートは、SWOT分析と市場戦略とともに、医療用吸入器市場の主要プレーヤーのプロフィールも提供します。また、レポートは、企業概要、過去 3 年間の財務情報、提供されるコンポーネントとサービス、過去 5 年間の重要な開発に関する情報を含む主要な市場プレーヤーに焦点を当てています。 - グラクソ・スミスクライン社- Koninklijke Philips NV - AstraZeneca - Cipla Inc. - Boehringer Ingelheim International GmbH - Beximco Pharmaceuticals Ltd - Merck & Co., Inc. - Teva Pharmaceutical Industries Ltd - Chiesi Farmaceutici SpA - Medisol Lifescience Pvt. Insight Partner の専任の調査および分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成されており、現在のレポートでいくつかのカスタマイズ オプションを提供しています。
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the Medical Inhaler Market in 2023?

North America dominated the Medical Inhaler Market in 2023

What is one of the main future trends of the Medical Inhaler Market ?

Increasingly Patient-Centric Designs is likely to remain the key trend during the forecast period.

Which region is expected to witness the fastest growth rate by 2031?

Asia Pacific region is likely to witness the fastest growth rate during the forecast period.

What are the driving factors impacting the Medical Inhaler Market ?

The Medical Inhaler Market drivers include the Increasing Prevalence of Respiratory Disorders, Technological Advancements in Inhaler Devices, Growing Awareness and Education over Respiratory Health

Who are the prominent players in Medical Inhaler Market ?

GlaxoSmithKline plc., Koninklijke Philips N.V., AstraZeneca, Cipla Inc., Boehringer Ingelheim International GmbH, Beximco Pharmaceuticals Ltd are some prominent players in the Medical Inhaler Market

What is the expected CAGR of the Medical Inhaler Market ?

The Medical Inhaler Market is estimated to witness a CAGR of 9.7% from 2023 to 2031

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. GlaxoSmithKline plc.
2. Koninklijke Philips N.V.
3. AstraZeneca
4. Cipla Inc.
5. Boehringer Ingelheim International GmbH
6. Beximco Pharmaceuticals Ltd
7. Merck & Co., Inc.
8. Teva Pharmaceutical Industries Ltd
9. Chiesi Farmaceutici SpA
10. Medisol Lifescience Pvt. Ltd

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.